200 related articles for article (PubMed ID: 3078955)
1. Elevated expression of c-myc proto-oncogene in scleroderma fibroblasts.
Trojanowska M; Wu LT; LeRoy EC
Oncogene; 1988 Oct; 3(4):477-81. PubMed ID: 3078955
[TBL] [Abstract][Full Text] [Related]
2. Proliferation of the human colon carcinoma cell line HT29: autocrine growth and deregulated expression of the c-myc oncogene.
Forgue-Lafitte ME; Coudray AM; Bréant B; Mester J
Cancer Res; 1989 Dec; 49(23):6566-71. PubMed ID: 2684395
[TBL] [Abstract][Full Text] [Related]
3. Two transient increases in c-myc gene expression during neuroectodermal differentiation of mouse embryonal carcinoma cells.
St-Arnaud R; Nepveu A; Marcu KB; McBurney MW
Oncogene; 1988 Nov; 3(5):553-9. PubMed ID: 3078960
[TBL] [Abstract][Full Text] [Related]
4. Proto-oncogene expression and nuclear factor specifically bound to c-myc gene in peripheral blood mononuclear cells from progressive systemic sclerosis patients as the indicator of clinical activity.
Deguchi Y; Negoro S; Kishimoto S
J Clin Lab Immunol; 1988 Aug; 26(4):163-8. PubMed ID: 3058983
[TBL] [Abstract][Full Text] [Related]
5. Dissociation of proto-oncogene induction from growth response in normal human fibroblasts.
Yaar M; Peacocke M; Cohen MS; Gilchrest BA
J Cell Physiol; 1990 Oct; 145(1):39-45. PubMed ID: 2120243
[TBL] [Abstract][Full Text] [Related]
6. Progressive relaxation of Go-arrest controls and altered responsiveness to insulin, EGF and thrombin in CCL39 lung fibroblasts over-expressing myc and ras oncogenes.
Pichon F; Seuwen K; Pouysségur J; Lagarde AE
Oncogene; 1988 Oct; 3(4):373-81. PubMed ID: 3078948
[TBL] [Abstract][Full Text] [Related]
7. Mouse fibroblasts transformed with the human c-myc gene express a high level of mRNA but a low level of c-myc protein and are non-tumorigenic in nude mice.
Ray R; Thomas S; Miller DM
Oncogene; 1989 May; 4(5):593-600. PubMed ID: 2657574
[TBL] [Abstract][Full Text] [Related]
8. Proto-oncogene expression in avian hematopoietic tissues.
Schuur ER; Baluda MA
Oncogene; 1991 Aug; 6(8):1409-15. PubMed ID: 1886713
[TBL] [Abstract][Full Text] [Related]
9. Transcription of the c-myc oncogene is altered in spontaneously immortalized rodent fibroblasts.
Tavassoli M; Shall S
Oncogene; 1988 Apr; 2(4):337-45. PubMed ID: 3283652
[TBL] [Abstract][Full Text] [Related]
10. Effects of interferon-beta on Daudi cells and on small cell lung carcinoma cells which over-express the c-myc oncogene.
Pape KA; Floyd-Smith G
Anticancer Res; 1989; 9(6):1737-42. PubMed ID: 2560625
[TBL] [Abstract][Full Text] [Related]
11. Neuroblastoma: inverse relationship between expression of N-myc and NGF-r.
Christiansen H; Christiansen NM; Wagner F; Altmannsberger M; Lampert F
Oncogene; 1990 Mar; 5(3):437-40. PubMed ID: 2156211
[TBL] [Abstract][Full Text] [Related]
12. Distinct mechanisms of c-myc and lymphokine gene expression in an antigen specific T cell clone.
Heckford SE; Gelmann EP; Matis LA
Oncogene; 1988 Oct; 3(4):415-21. PubMed ID: 3152599
[TBL] [Abstract][Full Text] [Related]
13. Regulation of C-myc and C-Ha-ras oncogene expression by cell shape.
Farrell RE; Greene JJ
J Cell Physiol; 1992 Nov; 153(2):429-35. PubMed ID: 1385453
[TBL] [Abstract][Full Text] [Related]
14. Alternative modes of c-myc regulation in growth factor-stimulated and differentiating cells.
Nepveu A; Levine RA; Campisi J; Greenberg ME; Ziff EB; Marcu KB
Oncogene; 1987; 1(3):243-50. PubMed ID: 2455262
[TBL] [Abstract][Full Text] [Related]
15. Differentiation of F9 cells is independent of c-myc expression.
Nishikura K; Kim U; Murray JM
Oncogene; 1990 Jul; 5(7):981-8. PubMed ID: 1695728
[TBL] [Abstract][Full Text] [Related]
16. c-Myc creates an activation loop by transcriptionally repressing its own functional inhibitor, hMad4, in young fibroblasts, a loop lost in replicatively senescent fibroblasts.
Marcotte R; Chen JM; Huard S; Wang E
J Cell Biochem; 2005 Dec; 96(5):1071-85. PubMed ID: 16167342
[TBL] [Abstract][Full Text] [Related]
17. Modulation of c-myc oncogene expression by phorbol ester and interferon-gamma: appraisal by flow cytometry.
Mohamed AN; Nakeff A; Mohammad RM; KuKuruga M; al-Katib A
Oncogene; 1988 Oct; 3(4):429-35. PubMed ID: 3152600
[TBL] [Abstract][Full Text] [Related]
18. Regulation of c-myc mRNA levels by insulin or platelet-poor plasma.
Gai XX; Rizzo MG; Valpreda S; Baserga R
Oncogene Res; 1989; 5(2):111-20. PubMed ID: 2691956
[TBL] [Abstract][Full Text] [Related]
19. Decreased steady state c-myc mRNA in activated T cell cultures from old humans is caused by a smaller proportion of T cells that transcribe the c-myc gene.
Gamble DA; Schwab R; Weksler ME; Szabo P
J Immunol; 1990 May; 144(9):3569-73. PubMed ID: 2184192
[TBL] [Abstract][Full Text] [Related]
20. Elevated expression of an exogenous c-myc gene is insufficient for transformation and tumorigenic conversion of established fibroblasts.
Zerlin M; Julius MA; Cerni C; Marcu KB
Oncogene; 1987 Mar; 1(1):19-27. PubMed ID: 3325875
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]